Jean-Simon Diallo

thumb image

Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute
Associate Scientist, Faculty of Medicine, University of Ottawa

 

Full Biography

 

Cancers of Interest

Sarcoma
Prostate
Breast

 

Research Interests and Clinical Approach

Oncolytic Virotherapy
Viral sensitizers
Combination Immunotherapy

 

Projects at BioCanRx

Development of Supporting Analytical Assays and Regulatory Compliance Package for Viral Sensitizer Technology Commercialization

 

Scalable Vector Manufacturing Enhancement Using Viral Sensitizers

 

Anti-DEC205 priming in heterologous prime-boost with OVs for sarcoma

 

Recent Articles

Researchers join the fight against COVID-19

 

BioCanRX and Partners Announce Funding for Eight New Projects

 

Introducing the winners of BioCanRx’s 2018 Summer Studentships

 

From Ottawa to Sao Paulo, Brazil: A BioCanRx Lab Exchange

 

BioCanRx and partners announce $6.5M in funding for three new projects including a clinical trial

 

Announcing the winners of BioCanRx’s 2017 Summer Studentships

 

BioCanRx investigators receive $5M to develop virus therapy for prostate cancer